Increased NT-pro-B-type natriuretic peptide independently predicts outcome following catheter ablation of atrial fibrillation

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 69, Issue 8, 2009, Pages 843-850

  Nilsson, Brian ^a   Goetze, Jens Peter ^a   Chen, Xu ^a   Pehrson, Steen ^a   Svendsen, Jesper Hastrup ^a,b,c  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b DANISH NATIONAL RESEARCH FOUNDATION   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Atrial fi brillation; Catheter ablation; NT proBNP; Pulmonary vein isolation

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ADULT; ARTICLE; CATHETER ABLATION; CONTROLLED STUDY; EXERCISE TEST; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PULMONARY VEIN;

ATRIAL FIBRILLATION; CATHETER ABLATION; EXERCISE TEST; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; RECURRENCE; TREATMENT OUTCOME;

EID: 72749083917     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.3109/00365510903318209     Document Type: Article

References (27)

1. Nilsson B, Chen X, Pehrson S, Jensen HL, Sondergaard L, Helvind M, Andersen LW, Svendsen JH. Acute fatal pulmonary vein occlusion after catheter ablation of atrial fibrillation. J Interv Card Electrophysiol 2004;11:127-130
2. Kottkamp H, Tanner H, Kobza R, Schirdewahn P, Dorszewski A, Gerds-Li JH, Carbucicchio C, Piorkowski C, Hindricks G. Time courses and quantitative analysis of atrial fibrillation episode number and duration after circular plus linear left atrial lesions: Trigger elimination or substrate modifi cation: Early or delayed cure? J Am Coll Cardiol 2004;44:869-877
3. Nilsson B, Chen X, Pehrson S, Kober L, Hilden J, Svendsen JH. Recurrence of pulmonary vein conduction and atrial fibrillation after pulmonary vein isolation for atrial fibrillation: A randomized trial of the ostial versus the extraostial ablation strategy. Am Heart J 2006;152:537-538
4. Fassini G, Riva S, Chiodelli R, Trevisi N, Berti M, Carbucicchio C, Maccabelli G, Giraldi F, Bella PD. Left mitral isthmus ablation associated with PV Isolation: Longterm results of a prospective randomized study. J Cardiovasc Electrophysiol 2005;16:1150-1156
5. Goetze JP, Friis-Hansen L, Rehfeld JF, Nilsson B, Svendsen JH. Atrial secretion of B-type natriuretic peptide. Eur Heart J 2006;27:1648-1650 Epub June 2006, Review.
6. Goetze JP. Biochemistry of pro-B-type natriuretic peptidederived peptides: The endocrine heart revisited. Clin Chem 2004;50:1503-1510
7. de Lemos JA, McGuire DK, Drazner MH. B-type natriuretic peptide in cardiovascular disease. Lancet 2003;362: 316-322
8. Ellinor PT, Low AF, Patton KK, Shea MA, Macrae CA. Discordant atrial natriuretic peptide and brain natriuretic peptide levels in lone atrial fibrillation. J Am Coll Cardiol 2005;45:82-86
9. Knudsen CW, Omland T, Clopton P, Westheim A, Wu AH, Duc P, McCord J, Nowak RM, Hollander JE, Storrow AB, Abraham WT, McCullough PA, Maisel A. Impact of atrial fibrillation on the diagnostic performance of B-type natriuretic peptide concentration in dyspneic patients: An analysis from the breathing not properly multinational study. J Am Coll Cardiol 2005;46:838-844 (Pubitemid 41224808)
10. Wozakowska-Kaplon B. Effect of sinus rhythm restoration on plasma brain natriuretic peptide in patients with atrial fibrillation. Am J Cardiol 2004;93:1555-1558 (Pubitemid 38749221)
11. Lellouche N, Berthier R, Mekontso-Dessap A, Braconnier F, Monin JL, Duval AM, Dubois-Randé JL, Guéret P, Garot J. Usefulness of plasma B-type natriuretic peptide in predicting recurrence of atrial fibrillation one year after external cardioversion. Am J Cardiol 2005;95:1380-1382
12. Levy S, Camm AJ, Saksena S, Aliot E, Breithardt G, Crijns HJ, Davies DW, Kay GN, Prystowsky EN, Sutton R, Waldo AL, Wyse DG. Working Group on Arrhythmias of European Society of Cardiology; Working Group of Cardiac Pacing of European Society of Cardiology; North American Society of Pacing and Electrophysiology. International consensus on nomenclature and classifi cation of atrial fibrillation: A collaborative project of the Working Group on Arrhythmias and the Working Group of Cardiac Pacing of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. J Cardiovasc Electrophysiol 2003;14:443-445 (Pubitemid 36529038)
13. Haissaguerre M, Jais P, Shah DC, Garrigue S, Takahashi A, Lavergne T, Hocini M, Peng JT, Roudaut R, Clémenty J. Electrophysiological end point for catheter ablation of atrial fibrillation initiated from multiple pulmonary venous foci. Circulation 2000;101:1409-1417
14. Pappone C, Oreto G, Rosanio S, Vicedomini G, Tocchi M, Gugliotta F, Salvati A, Dicandia C, Calabrò MP, Mazzone P, Ficarra E, Di Gioia C, Gulletta S, Nardi S, Santinelli V, Benussi S, Alfi eri O. Atrial electroanatomic remodeling after circumferential radiofrequency pulmonary vein ablation: Effi cacy of an anatomic approach in a large cohort of patients with atrial fibrillation. Circulation 2001;104:2539-2544
15. Steele IC, McDowell G, Moore A, Campbell NP, Shaw C, Buchanan KD, Nicholls DP. Responses of atrial natriuretic peptide and brain natriuretic peptide to exercise in patients with chronic heart failure and normal control subjects. Eur J Clin Investig 1997;27:270-276
16. Wijbenga JA, Balk AH, Boomsma F, Man in 't Veld AJ, Hall C. Cardiac peptides differ in their response to exercise. Implications for patients with heart failure in clinical practice. Eur Heart J 1999; 20:1424-8.
17. Kato M, Kinugawa T, Ogino K, Endo A, Osaki S, Igawa O, Hisatome I, Shigemasa C. Augmented response in plasma brain natriuretic peptide to dynamic exercise in patients with left ventricular dysfunction and congestive heart failure. J Intern Med 2000;248:309-315
18. Braunwald E. Biomarkers in heart failure. N Engl J Med 2008;358:2148-2159
19. Marumoto K, Hamada M, Hiwada K. Increased secretion of atrial and brain natriuretic peptides during acute myocardial ischaemia induced by dynamic exercise in patients with angina pectoris. Clin Sci 1995;88:551-556
20. Matsumoto A, Hirata Y, Momomura S, Suzuki E, Yokoyama I, Sata M, Ohtani Y, Serizawa T. Effects of exercise on plasma level of brain natriuretic peptide in congestive heart failure with and without left ventricular dysfunction. Am Heart J 1995;129:139-145
21. Engelmann MD, Niemann L, Kanstrup IL, Skagen K, Godtfredsen J. Natriuretic peptide response to dynamic exercise in patients with atrial fibrillation. Int J Cardiol 2005;105:31-39
22. Chidsey CA, Harrison DC, Braunwald E. Augmentation of the plasma norepinephrine response to exercise in patients with congestive heart failure. N Engl J Med 1962;267: 650-654
23. Latini R, Masson S, Anand I, Salio M, Hester A, Judd D, Barlera S, Maggioni AP, Tognoni G, Cohn JN; Val-HeFT Investigators. The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFT. Eur Heart J 2004;25:292-299
24. Wijffels MCEF, Kirchhof CJHJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation: A study in awake chronically instrumented goats. Circulation 1995;92:1954-1968
25. Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 1997;96: 1180-1184
26. Date T, Yamane T, Inada K, Matsuo S, Miyanaga S, Sugimoto K, Shibayama K, Taniguchi I, Mochizuki S. Plasma brain natriuretic peptide concentrations in patients undergoing pulmonary vein isolation. Heart 2006;92: 1623-1627
27. Yamada T, Murakami Y, Okada T, Okamoto M, Shimizu T, Toyama J, Yoshida Y, Tsuboi N, Ito T, Muto M, Kondo T, Inden Y, Hirai M, Murohara T. Plasma atrial natriuretic Peptide and brain natriuretic Peptide levels after radiofrequency catheter ablation of atrial fibrillation. Am J Cardiol 2006;97:1741-1744